Core Insights - eHealth has announced a new growth strategy focused on building trusted, lifelong customer relationships to enhance member lifetime value and retention while expanding its product offerings [1][2] - A recent survey indicates that a significant majority of Americans recognize the need for year-round insurance advisory support, with 87% valuing ongoing assistance in understanding coverage options [1][2] Group 1: New Strategy Overview - The new strategy shifts from a transaction-driven model to an ongoing relationship model, supporting consumers throughout their health journey, including Medicare and ACA plan enrollment [1] - eHealth aims to strengthen relationships with consumers by providing year-round support, conducting needs assessments, and managing plan changes proactively [1][2] Group 2: Market Insights and Consumer Needs - Survey findings reveal that 90% of Americans believe the current health insurance selection process is broken, highlighting a demand for improved support [1] - 97% of working-age Americans are interested in personalized plans tailored to their specific needs, indicating a market opportunity for customized insurance solutions [1] Group 3: Technology and Service Expansion - eHealth plans to invest in enhanced technology and integrated data systems to streamline shopping and enrollment processes, leveraging AI and advanced analytics [1] - The company intends to expand its portfolio of ancillary products and services, building on the growth achieved with Hospital Indemnity Plans in 2025 [1] Group 4: Focus on Diverse Consumer Segments - eHealth is expanding its support for consumers accessing individual coverage through employers, including Individual Coverage Health Reimbursement Arrangements (ICHRA) [1] - The strategy is expected to improve brand recognition and member retention while driving increased lifetime value [1]

Core Viewpoint - Ramaco Resources, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its mining activities at the Brook Mine during the class period from July 31, 2025, to October 23, 2025 [1] Group 1: Allegations - The lawsuit claims that Ramaco did not commence any significant mining activity at the Brook Mine after groundbreaking [1] - It is alleged that no active work was taking place at the Brook Mine, leading to an overstatement of development progress [1] - The positive statements made by the company about its business, operations, and prospects were materially misleading and lacked a reasonable basis [1] Group 2: Class Action Details - The deadline for shareholders to register for the class action and seek lead plaintiff status is March 31, 2026 [1] - Shareholders who purchased shares of METC during the specified class period are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [1] - Participation in the case does not require appointment as lead plaintiff, and there is no cost or obligation to participate [1]

Core Insights - AI unicorn Anthropic has raised $30 billion in fresh funding, resulting in a post-money valuation of $380 billion [1] Group 1: Company Developments - Anthropic's recent funding round significantly increased its valuation, highlighting the growing investor interest in AI technologies [1] - The funding round occurred just a week prior to the announcement, indicating a rapid influx of capital into the AI sector [1] Group 2: Market Context - The overall equities market showed little change, although technology shares contributed to boosting major indices on February 18, 2026 [1] - The NYSE provided a pre-market update, reflecting ongoing market activities and investor sentiments [1]

Core Insights - CME Group will launch 24/7 trading for its regulated Cryptocurrency futures and options starting May 29, pending regulatory review [1][2] - Client demand for risk management in the digital asset market has reached an all-time high, resulting in a record $3 trillion in notional volume for Cryptocurrency futures and options in 2025 [2] - The continuous trading will include a two-hour weekly maintenance period over the weekend, with holiday or weekend trades dated to the following business day [2] Company Performance - CME Group has reported an average daily volume (ADV) of 407,200 contracts, which is a 46% increase year-over-year, and an average daily open interest of 335,400 contracts, up 7% year-over-year [5] - The futures ADV specifically reached 403,900 contracts, marking a 47% increase year-over-year [5] Market Position - CME Group is recognized as the world's leading derivatives marketplace, facilitating trading across various asset classes including interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products, and metals [3] - The company operates the CME Globex platform for futures and options trading, BrokerTec for fixed income trading, and EBS for foreign exchange trading, alongside being a major central counterparty clearing provider [3]

reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure. [https://nauticusrobotics.com/]Cautionary Language Regarding Forward- Looking StatementsThis press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Act"), and are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Act as well as p ...

Group 1 - Shutterstock expresses satisfaction with the UK Competition and Markets Authority's (CMA) provisional decision regarding the merger with Getty Images, indicating no expected competition issues in the global stock content market [1] - The company disagrees with the CMA's finding that the merger may lead to a 'substantial lessening of competition' in the UK Editorial market, arguing that the analysis does not accurately reflect the UK market dynamics and customer alternatives [1] - Shutterstock plans to engage constructively with the CMA and will respond to the interim report according to the CMA's timeline, while also cooperating with the U.S. Department of Justice in its review [1] Group 2 - Shutterstock is positioned as a provider of scalable creative and GenAI solutions, leveraging a global network of creators and advanced technology to enhance business effectiveness [1] - The company boasts one of the largest and most diverse collections of high-quality licensable assets, data, AI solutions, and full-service studio production capabilities [1]

Core Insights - Calvin Klein Fragrances has launched a new collection called euphoria elixirs, featuring three distinct parfum intense creations, with GRAMMY® Award-winning artist ROSALÃ A as the face of the campaign [1][2] - The euphoria elixirs are designed to explore themes of confidence, pleasure, and sensuality, with a focus on the key ingredient, vanilla, presented in three interpretations: magnetic elixir, bold elixir, and solar elixir [1][2] Product Details - The euphoria elixirs collection includes three scents: - **Magnetic Elixir**: A musky vanilla fragrance that combines Dancing Lady Orchid and ambrette absolute, designed to evoke effortless confidence and sensuality [1][2] - **Bold Elixir**: A woody vanilla scent featuring oakwood and smoky orchid, aimed at conveying intensity and depth [1][2] - **Solar Elixir**: A bright and joyful fragrance that pairs vanilla with mango, inspired by the blooming vanilla flower [1][2] - All three scents have an ultra-concentration of 28% or more, marking the highest fragrance concentration for Calvin Klein Fragrances [1][2] Packaging and Pricing - The packaging for the euphoria elixirs has been redesigned with vibrant colors: magnetic pink, bold purple, and solar yellow, reflecting youthful energy [1][2] - The euphoria elixirs will be available starting March 1, 2026, with pricing set at $129 for 100ml, $99 for 50ml, $79 for 30ml, and $36 for 10ml [1][2] Brand Background - Calvin Klein is a leading global fashion lifestyle brand founded in New York in 1968, with global retail sales of approximately $9 billion in 2024 [1][2] - Coty Inc., founded in Paris in 1904, is one of the largest beauty companies globally, with a diverse portfolio across fragrance, color cosmetics, and skin and body care [1][2]

Core Viewpoint - AudioEye, Inc. will hold a conference call on March 5, 2026, to discuss its financial results for Q4 and the full year of 2025, with results to be released prior to the call [1] Group 1: Conference Call Details - The conference call is scheduled for Thursday, March 5, 2026, at 4:30 p.m. Eastern Time [1] - U.S. dial-in number for the call is 877-407-8289, and the international number is 201-689-8341 [1] - A live webcast will be available, and a replay will be accessible for 90 days on the company's investor relations website [1] Group 2: Company Overview - AudioEye is a leading digital accessibility company focused on ensuring digital experiences are accessible for all [1] - The company has over 131,000 customers, including notable brands like Samsung, Calvin Klein, and Samsonite [1] - AudioEye holds 26 U.S. patents and offers a comprehensive solution that includes 24/7 accessibility monitoring and automated WCAG issue testing [1]

Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion, providing U.S. clinicians dir ...

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping [Accessibility Statement] Skip NavigationFoundational Patent Strengthens AI Moat Across Multimodal Data Standardization, Disease Stratification and Gene MappingSACRAMENTO, Calif., Feb. 19, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI), an AI-driven biotechnology company advancing precision therapeutics in central nervous system (CNS) disorders and oncology, as well as solutions for ...